Apollo Management Holdings’s MaxCyte MXCT Stock Holding History

Apollo Management Holdings’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Hold	307,987	–	–	﹤0.01%	74
2026 Q1	$216K	Hold	307,987	–	–	﹤0.01%	76
2025 Q4	$477K	Hold	307,987	–	–	﹤0.01%	97
2025 Q3	$487K	Hold	307,987	–	–	0.01%	42
2025 Q2	$671K	Hold	307,987	–	–	0.01%	38
2025 Q1	$841K	Hold	307,987	–	–	0.02%	36
2024 Q4	$1.28M	Hold	307,987	–	–	0.02%	38
2024 Q3	$1.2M	Hold	307,987	–	–	0.02%	33
2024 Q2	$1.21M	Hold	307,987	–	–	0.02%	36
2024 Q1	$1.29M	Hold	307,987	–	–	0.02%	39
2023 Q4	$1.45M	Hold	307,987	–	–	0.01%	42
2023 Q3	$961K	Hold	307,987	–	–	0.01%	52
2023 Q2	$1.41M	Hold	307,987	–	–	0.01%	57
2023 Q1	$1.52M	Buy	307,987 +64,603	+27%	+$318K	0.01%	105
2022 Q4	$1.33M	Hold	243,384	–	–	0.01%	131
2022 Q3	$1.58M	Hold	243,384	–	–	0.01%	154
2022 Q2	$1.15M	Hold	243,384	–	–	0.01%	178
2022 Q1	$1.7M	Hold	243,384	–	–	0.01%	241
2021 Q4	$2.48M	Hold	243,384	–	–	0.01%	165
2021 Q3	$2.97M	Buy	+243,384	New	+$3.67M	0.01%	102

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Apollo Management Holdings's MXCT Position: Q2 2026 in Review

Apollo Management Holdings held its MaxCyte (MXCT) position steady in Q2 2026 at 307,987 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #74.

Apollo Management Holdings first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.97M in Q3 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Apollo Management Holdings held 307,987 shares of MaxCyte worth $379K as of Q2 2026.
Apollo Management Holdings left its MaxCyte share count unchanged in Q2 2026.
MaxCyte made up ﹤0.01% of Apollo Management Holdings's portfolio in Q2 2026, its #74 holding.
Apollo Management Holdings first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
Apollo Management Holdings's MaxCyte position peaked at $2.97M in Q3 2021.
122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Apollo Management Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.